Walter J. Brecht
Walter J. Brecht publishes mostly in Molecular Biology, Physiology and Surgery, on topics such as Alzheimer's disease research and treatments, Diabetes, Cardiovascular Risks, and Lipoproteins and Lipid metabolism and disorders.
- World rank
- #818,450 of 7,710,434 ranked researchers
- Rank in United States
- #272,562 of 1,627,098
- Works
- 26
- Citations
- 2.5k
- Citations per work
- 97.0
What does Walter J. Brecht research?
Walter J. Brecht's work is mostly in Medicine (35%), Biochemistry, Genetics and Molecular Biology (15%), Neuroscience (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else1143.8%
- Health Sciences934.9%
- Medicine934.9%
- Life Sciences621.3%
- 1Molecular Biology15% of their works
- 2Physiology11% of their works
- 3Surgery9% of their works
- 4Cardiology and Cardiovascular Medicine8% of their works
- 5Endocrinology, Diabetes and Metabolism8% of their works
- 6Cellular and Molecular Neuroscience6% of their works
Research topics
- Alzheimer's disease research and treatments
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Lipid metabolism and disorders
- Nuclear Receptors and Signaling
- Lipoproteins and Cardiovascular Health
- Listeria monocytogenes in Food Safety
- Peroxisome Proliferator-Activated Receptors
- Pharmacogenetics and Drug Metabolism
Which keywords describe Walter J. Brecht's research?
The keywords of their largest research topics: Neurodegeneration, Atherosclerosis, Metabolic Syndrome, Amyloid Hypothesis, Diabetes, Obesity, Tau Pathology and Cardiovascular Disease.
- Peroxisome Proliferator-Activated Receptors
- Listeria monocytogenes
- Cytochrome P450
- Nurr1
- Cholesterol-lowering
- ANGPTL3
- Insulin Resistance
- Cardiovascular Disease
- Obesity
- Amyloid Hypothesis
- Atherosclerosis
- Neurodegeneration
- Metabolic Syndrome
- Diabetes
- Tau Pathology
- Inflammation
- Nuclear Receptors
- Lipoprotein Lipase
- NR4A2
- Statins
- Foodborne Illness
- PPARs
- Pharmacogenetics
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 23 words, with their numbers
- Neurodegeneration102 topics
- Atherosclerosis92 topics
- Metabolic Syndrome92 topics
- Amyloid Hypothesis71 topic
- Diabetes72 topics
- Obesity72 topics
- Tau Pathology71 topic
- Cardiovascular Disease51 topic
- Inflammation52 topics
- Insulin Resistance51 topic
- Nuclear Receptors52 topics
- ANGPTL341 topic
- Lipoprotein Lipase41 topic
- Cholesterol-lowering31 topic
- NR4A231 topic
- Nurr131 topic
- Statins31 topic
- Cytochrome P45021 topic
- Foodborne Illness21 topic
- Listeria monocytogenes21 topic
- PPARs21 topic
- Peroxisome Proliferator-Activated Receptors21 topic
- Pharmacogenetics21 topic
Where does Walter J. Brecht work?
Walter J. Brecht's main affiliation in the publication record is Gladstone Institutes, United States.
How many publications and citations does Walter J. Brecht have?
OpenAlex counts 26 works and 2,521 citations for Walter J. Brecht, an h-index of 15, ranking #818,450 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Walter J. Brecht. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.